Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activityMAKOVEC, F; BANI, M; CHISTE, R et al.Arzneimittel-Forschung. 1986, Vol 36, Num 1, pp 98-102, issn 0004-4172Article

Distribution of tiropramide and metabolites after single intravenous or peroral administration of ¹⁴C-tiropramide to the ratSETNIKAR, I; MAKOVEC, F; CHISTE, R et al.Arzneimittel-Forschung. 1989, Vol 39, Num 5, pp 579-586, issn 0004-4172Article

New glutamic and aspartic derivatives with potent CCK-antagonistic activityMAKOVIC, F; CHISTE, R; BANI, M et al.European journal of medicinal chemistry. 1986, Vol 21, Num 1, pp 9-20, issn 0223-5234Article

Identification of metabolites of tiropramide in human urineARIGONI, R; CHISTE, R; MAKOVEC, F et al.Biomedical & environmental mass spectrometry. 1988, Vol 15, Num 4, pp 205-209, issn 0887-6134Article

Pharmacokinetics of tiropramide after single doses in manARIGONI, R; CHISTE, R; DROVANTI, A et al.Arzneimittel-Forschung. 1986, Vol 36, Num 4, pp 738-744, issn 0004-4172Article

Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and miceMAKOVEC, F; BANI, M; CEREDA, R et al.Peptides (New York, NY. 1980). 1986, Vol 7, Num 6, pp 1159-1164, issn 0196-9781Article

Loxiglumide protects against experimental pancreatitisSETNIKAR, I; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 10, pp 1172-1174, issn 0004-4172Article

Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in ratsMAKOVEC, F; BANI, M; CHISTE, R et al.Regulatory peptides. 1986, Vol 16, Num 3-4, pp 281-290, issn 0167-0115Article

New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activityMAKOVEC, F; CHISTE, R; BANI, M et al.Arzneimittel-Forschung. 1985, Vol 35, Num 7, pp 1048-1051, issn 0004-4172Article

Metabolism and excretion of ¹⁴C-tiropramide after single intravenous or peroral administration to the ratSETNIKAR, I; MAKOVEC, F; CHISTE, R et al.Arzneimittel-Forschung. 1989, Vol 39, Num 3, pp 328-334, issn 0004-4172Article

Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonistSETNIKAR, I; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 6, pp 703-707, issn 0004-4172Article

Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonistsMAKOVEC, F; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 11, pp 1265-1268, issn 0004-4172Article

Plasma levels of proglumetacin and its metabolites after intravenous or oral administration in the dogSETNIKAR, I; ARIGONI, R; CHISTE, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 6, pp 698-702, issn 0004-4172Article

Pharmacokinetics of loxiglumide after single intravenous or oral doses in manSETNIKAR, I; CHISTE, R; MAKOVEC, F et al.Arzneimittel-Forschung. 1988, Vol 38, Num 5, pp 716-720, issn 0004-4172Article

Tiropramide and metabolites in blood and plasma after intravenous or peroral administration of ¹⁴C-tiropramide to the ratSETNIKAR, I; MAKOVEC, F; CHISTE, R et al.Arzneimittel-Forschung. 1988, Vol 38, Num 12, pp 1815-1819, issn 0004-4172Article

Antispasmodic activity on the gallbladder of the mouse of CR 1409 (Lorglumide) a potent antagonist of peripheral CCKMAKOVEC, F; BANI, M; CEREDA, R et al.Pharmacological research communications. 1987, Vol 19, Num 1, pp 41-51, issn 0031-6989Article

Anticholecystokinin activities of loxiglumideSETNIKAR, I; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 10, pp 1168-1171, issn 0004-4172Article

Pharmacokinetics and metabolism of [¹⁴C]-proglumetacin after oral administration in the ratMAKOVEC, F; CHISTE, R; PERIS, I. W et al.Arzneimittel-Forschung. 1987, Vol 37, Num 7, pp 806-813, issn 0004-4172Article